BECTON, DICKINSON AND COMPANY Revenue
BECTON, DICKINSON AND COMPANY (BDX) reported Revenue of $4.98 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY revenues for the quarter ending 2026-06-30 was $4.98B, a 5.44% increase year-over-year.
- BECTON, DICKINSON AND COMPANY revenues for the quarter ending 2026-03-31 was $4.71B, a 5.22% increase year-over-year.
- BECTON, DICKINSON AND COMPANY revenues for the quarter ending 2025-12-31 was $5.25B, a 1.63% increase year-over-year.
- BECTON, DICKINSON AND COMPANY revenues for the quarter ending 2025-09-30 was $8.30B, a 52.68% increase year-over-year.
- BECTON, DICKINSON AND COMPANY revenues for fiscal 2025 was $21.84B, a 8.24% increase from fiscal 2024.
- BECTON, DICKINSON AND COMPANY revenues for fiscal 2024 was $20.18B, a 4.16% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY revenues for fiscal 2023 was $19.37B, a 2.66% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY revenues for fiscal 2022 was $18.87B, a 1.36% decline from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.98B 10-Q · filed 2026-08-06 | $9.70B derived: sum of 2 quarters · filed 2026-08-06 | $14.18B 10-Q · filed 2026-08-06 | $23.25B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.71B 10-Q · filed 2026-05-07 | $9.20B 10-Q · filed 2026-05-07 | $18.27B derived: sum of 3 quarters · filed 2026-05-07 | $22.99B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $5.25B 10-Q · filed 2026-02-09 | $13.55B derived: sum of 2 quarters · filed 2026-02-09 | $18.28B derived: sum of 3 quarters · filed 2026-08-06 | $22.76B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-09-30 | $8.30B derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $13.03B derived: sum of 2 quarters · filed 2026-08-06 | $17.51B derived: sum of 3 quarters · filed 2026-08-06 | $21.84B 10-K · filed 2025-11-25 | ||||
| 2025-06-30 | $4.73B 10-Q · filed 2026-08-06 | $5.51B 10-Q · filed 2025-08-07 | $9.21B derived: sum of 2 quarters · filed 2026-08-06 | $13.54B 10-Q · filed 2026-08-06 | $15.95B 10-Q · filed 2025-08-07 | $19.81B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $4.48B 10-Q · filed 2026-05-07 | $5.27B 10-Q · filed 2025-05-01 | $8.81B 10-Q · filed 2026-05-07 | $10.44B 10-Q · filed 2025-05-01 | $15.09B derived: sum of 3 quarters · filed 2026-05-07 | $20.07B derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $5.17B 10-Q · filed 2026-02-09 | $10.61B derived: sum of 2 quarters · filed 2026-02-09 | $15.60B derived: sum of 3 quarters · filed 2026-02-09 | $20.64B derived: sum of 4 quarters · filed 2026-02-09 | ||||
| 2024-09-30 | $5.44B derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $10.43B derived: sum of 2 quarters · filed 2025-11-25 | $15.47B derived: sum of 3 quarters · filed 2025-11-25 | $20.18B 10-K · filed 2025-11-25 | ||||
| 2024-06-30 | $4.99B 10-Q · filed 2025-08-07 | $10.04B derived: sum of 2 quarters · filed 2025-08-07 | $14.74B 10-Q · filed 2025-08-07 | $19.83B derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2024-03-31 | $5.04B 10-Q · filed 2025-05-01 | $9.75B 10-Q · filed 2025-05-01 | $14.84B derived: sum of 3 quarters · filed 2025-11-25 | $19.72B derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-12-31 | $4.71B 10-Q · filed 2025-02-06 | $9.79B derived: sum of 2 quarters · filed 2025-11-25 | $14.67B derived: sum of 3 quarters · filed 2025-11-25 | $19.49B derived: sum of 4 quarters · filed 2025-11-25 | ||||
| 2023-09-30 | $5.09B derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $9.96B derived: sum of 2 quarters · filed 2025-11-25 | $14.79B derived: sum of 3 quarters · filed 2025-11-25 | $19.37B 10-K · filed 2025-11-25 | ||||
| 2023-06-30 | $4.88B 10-Q · filed 2024-08-01 | $9.70B derived: sum of 2 quarters · filed 2024-08-01 | $14.29B 10-Q · filed 2024-08-01 | $19.05B derived: sum of 4 quarters · filed 2024-11-27 | ||||
| 2023-03-31 | $4.82B 10-Q · filed 2024-05-02 | $9.41B 10-Q · filed 2024-05-02 | $14.17B derived: sum of 3 quarters · filed 2024-11-27 | $18.81B derived: sum of 4 quarters · filed 2024-11-27 | ||||
| 2022-12-31 | $4.59B 10-Q · filed 2024-02-01 | $9.35B derived: sum of 2 quarters · filed 2024-11-27 | $13.99B derived: sum of 3 quarters · filed 2024-11-27 | $18.74B derived: sum of 4 quarters · filed 2024-11-27 | ||||
| 2022-09-30 | $4.76B derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $9.40B derived: sum of 2 quarters · filed 2024-11-27 | $14.15B derived: sum of 3 quarters · filed 2024-11-27 | $18.87B 10-K · filed 2024-11-27 | ||||
| 2022-06-30 | $4.64B 10-Q · filed 2023-08-03 | $9.39B derived: sum of 2 quarters · filed 2023-08-03 | $14.11B 10-Q · filed 2023-08-03 | $18.96B derived: sum of 4 quarters · filed 2023-11-21 | ||||
| 2022-03-31 | $4.75B 10-Q · filed 2023-05-04 | $5.01B 10-Q · filed 2022-05-05 | $9.47B 10-Q · filed 2023-05-04 | $10.01B 10-Q · filed 2022-05-05 | $14.32B derived: sum of 3 quarters · filed 2023-11-21 | $18.92B derived: sum of 4 quarters · filed 2023-11-21 | ||
| 2021-12-31 | $4.72B 10-Q · filed 2023-02-02 | $5.00B 10-Q · filed 2022-02-03 | $9.57B derived: sum of 2 quarters · filed 2023-11-21 | $14.17B derived: sum of 3 quarters · filed 2023-11-21 | $19.08B derived: sum of 4 quarters · filed 2023-11-21 | |||
| 2021-09-30 | $4.85B derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $9.46B derived: sum of 2 quarters · filed 2023-11-21 | $14.36B derived: sum of 3 quarters · filed 2023-11-21 | $19.13B 10-K · filed 2023-11-21 | $20.25B 10-K · filed 2021-11-24 | |||
| 2021-06-30 | $4.61B 10-Q · filed 2022-08-04 | $4.89B 10-Q · filed 2021-08-05 | $9.51B derived: sum of 2 quarters · filed 2022-08-04 | $14.28B 10-Q · filed 2022-08-04 | $15.11B 10-Q · filed 2021-08-05 | $19.61B derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $4.91B 10-Q · filed 2022-05-05 | $10.22B 10-Q · filed 2022-05-05 | $15.01B derived: sum of 3 quarters · filed 2022-05-05 | $18.86B derived: sum of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | $5.32B 10-Q · filed 2022-02-03 | $10.10B derived: sum of 2 quarters · filed 2022-02-03 | $13.95B derived: sum of 3 quarters · filed 2022-02-03 | $18.21B derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-09-30 | $4.78B 10-K · filed 2020-11-25 | $8.64B derived: sum of 2 quarters · filed 2021-08-05 | $12.89B derived: sum of 3 quarters · filed 2021-08-05 | $16.07B 10-K · filed 2022-11-22 | $17.12B 10-K · filed 2020-11-25 | |||
| 2020-06-30 | $3.85B 10-Q · filed 2021-08-05 | $8.11B derived: sum of 2 quarters · filed 2021-08-05 | $12.33B 10-Q · filed 2021-08-05 | $16.92B derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $4.25B 10-Q · filed 2021-05-06 | $8.48B 10-Q · filed 2021-05-06 | $13.06B derived: sum of 3 quarters · filed 2021-05-06 | $17.41B derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $4.22B 10-Q · filed 2021-02-04 | $8.81B derived: sum of 2 quarters · filed 2021-02-04 | $13.16B derived: sum of 3 quarters · filed 2021-02-04 | $17.35B derived: sum of 4 quarters · filed 2021-02-04 | ||||
| 2019-09-30 | $4.58B 10-K · filed 2020-11-25 | $8.93B derived: sum of 2 quarters · filed 2020-11-25 | $13.13B derived: sum of 3 quarters · filed 2020-11-25 | $17.29B 10-K · filed 2021-11-24 | ||||
| 2019-06-30 | $4.35B 10-K · filed 2020-11-25 | $8.54B derived: sum of 2 quarters · filed 2020-11-25 | $12.71B 10-Q · filed 2020-08-06 | $17.11B derived: sum of 4 quarters · filed 2020-11-25 | ||||
| 2019-03-31 | $4.20B 10-K · filed 2020-11-25 | $8.36B 10-Q · filed 2020-05-07 | $12.76B derived: sum of 3 quarters · filed 2020-11-25 | $17.04B derived: sum of 4 quarters · filed 2020-11-25 | ||||
| 2018-12-31 | $4.16B 10-K · filed 2020-11-25 | $8.56B derived: sum of 2 quarters · filed 2020-11-25 | $12.84B derived: sum of 3 quarters · filed 2020-11-25 | $17.06B derived: sum of 4 quarters · filed 2020-11-25 | ||||
| 2018-09-30 | $4.40B 10-K · filed 2019-11-27 | $8.68B derived: sum of 2 quarters · filed 2019-11-27 | $12.90B derived: sum of 3 quarters · filed 2019-11-27 | $15.98B 10-K · filed 2020-11-25 | ||||
| 2018-06-30 | $4.28B 10-K · filed 2019-11-27 | $8.50B derived: sum of 2 quarters · filed 2019-11-27 | $11.58B 10-Q · filed 2019-08-06 | $14.75B derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2018-03-31 | $4.22B 10-K · filed 2019-11-27 | $7.30B 10-Q · filed 2019-05-09 | $10.47B derived: sum of 3 quarters · filed 2019-11-27 | $13.50B derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2017-12-31 | $3.08B 10-K · filed 2019-11-27 | $6.25B derived: sum of 2 quarters · filed 2019-11-27 | $9.28B derived: sum of 3 quarters · filed 2019-11-27 | $12.25B derived: sum of 4 quarters · filed 2019-11-27 | ||||
| 2017-09-30 | $3.17B 10-K · filed 2018-11-21 | $6.20B derived: sum of 2 quarters · filed 2018-11-21 | $9.17B derived: sum of 3 quarters · filed 2018-11-21 | $12.09B 10-K · filed 2019-11-27 | ||||
| 2017-06-30 | $3.04B 10-K · filed 2018-11-21 | $6.00B derived: sum of 2 quarters · filed 2018-11-21 | $8.93B 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | $2.97B 10-K · filed 2018-11-21 | $5.89B derived: sum of 2 quarters · filed 2018-11-21 | ||||||
| 2016-12-31 | $2.92B 10-K · filed 2018-11-21 | |||||||
| 2016-09-30 | $12.48B 10-K · filed 2018-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |